The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prenatal and Newborn Genetic Testing-Global Market Insights and Sales Trends 2025
Synopsis
The global Prenatal and Newborn Genetic Testing market size is expected to reach US$ 2917.1 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Prenatal and Newborn Genetic Testing in various end use industries. The expanding demands from the Hospitals, Diagnostic Organization and Other, are propelling Prenatal and Newborn Genetic Testing market. Array-Comparative Genetic Hybridization(aCGH), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fluorescence In-Situ Hybridization(FISH) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Prenatal and Newborn Genetic Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Prenatal and Newborn Genetic Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prenatal and Newborn Genetic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prenatal and Newborn Genetic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prenatal and Newborn Genetic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prenatal and Newborn Genetic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prenatal and Newborn Genetic Testing covered in this report include Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics and Quest Diagnostic, etc.
The global Prenatal and Newborn Genetic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom
Global Prenatal and Newborn Genetic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prenatal and Newborn Genetic Testing market, Segment by Type:
Array-Comparative Genetic Hybridization(aCGH)
Fluorescence In-Situ Hybridization(FISH)
Polymerase Chain Reaction(PCR)
Global Prenatal and Newborn Genetic Testing market, by Application
Hospitals
Diagnostic Organization
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prenatal and Newborn Genetic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Prenatal and Newborn Genetic Testing market size is expected to reach US$ 2917.1 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Prenatal and Newborn Genetic Testing in various end use industries. The expanding demands from the Hospitals, Diagnostic Organization and Other, are propelling Prenatal and Newborn Genetic Testing market. Array-Comparative Genetic Hybridization(aCGH), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fluorescence In-Situ Hybridization(FISH) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Prenatal and Newborn Genetic Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Prenatal and Newborn Genetic Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prenatal and Newborn Genetic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prenatal and Newborn Genetic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prenatal and Newborn Genetic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prenatal and Newborn Genetic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prenatal and Newborn Genetic Testing covered in this report include Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics and Quest Diagnostic, etc.
The global Prenatal and Newborn Genetic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom
Global Prenatal and Newborn Genetic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prenatal and Newborn Genetic Testing market, Segment by Type:
Array-Comparative Genetic Hybridization(aCGH)
Fluorescence In-Situ Hybridization(FISH)
Polymerase Chain Reaction(PCR)
Global Prenatal and Newborn Genetic Testing market, by Application
Hospitals
Diagnostic Organization
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prenatal and Newborn Genetic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Prenatal and Newborn Genetic Testing
1.1 Prenatal and Newborn Genetic Testing Market Overview
1.1.1 Prenatal and Newborn Genetic Testing Product Scope
1.1.2 Prenatal and Newborn Genetic Testing Market Status and Outlook
1.2 Global Prenatal and Newborn Genetic Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Prenatal and Newborn Genetic Testing Market Size by Region (2018-2029)
1.4 Global Prenatal and Newborn Genetic Testing Historic Market Size by Region (2018-2023)
1.5 Global Prenatal and Newborn Genetic Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Prenatal and Newborn Genetic Testing Market Size (2018-2029)
1.6.1 North America Prenatal and Newborn Genetic Testing Market Size (2018-2029)
1.6.2 Europe Prenatal and Newborn Genetic Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size (2018-2029)
1.6.4 Latin America Prenatal and Newborn Genetic Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size (2018-2029)
2 Prenatal and Newborn Genetic Testing Market by Type
2.1 Introduction
2.1.1 Array-Comparative Genetic Hybridization(aCGH)
2.1.2 Fluorescence In-Situ Hybridization(FISH)
2.1.3 Polymerase Chain Reaction(PCR)
2.2 Global Prenatal and Newborn Genetic Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Prenatal and Newborn Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Prenatal and Newborn Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Prenatal and Newborn Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Prenatal and Newborn Genetic Testing Revenue Breakdown by Type (2018-2029)
3 Prenatal and Newborn Genetic Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Organization
3.1.3 Other
3.2 Global Prenatal and Newborn Genetic Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Prenatal and Newborn Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Prenatal and Newborn Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Prenatal and Newborn Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Prenatal and Newborn Genetic Testing Revenue Breakdown by Application (2018-2029)
4 Prenatal and Newborn Genetic Testing Competition Analysis by Players
4.1 Global Prenatal and Newborn Genetic Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2022)
4.3 Date of Key Players Enter into Prenatal and Newborn Genetic Testing Market
4.4 Global Top Players Prenatal and Newborn Genetic Testing Headquarters and Area Served
4.5 Key Players Prenatal and Newborn Genetic Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Prenatal and Newborn Genetic Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche Diagnostic
5.1.1 Roche Diagnostic Profile
5.1.2 Roche Diagnostic Main Business
5.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.1.4 Roche Diagnostic Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Diagnostic Recent Developments
5.2 Elitech Group
5.2.1 Elitech Group Profile
5.2.2 Elitech Group Main Business
5.2.3 Elitech Group Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.2.4 Elitech Group Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Elitech Group Recent Developments
5.3 Myriad Genetics
5.3.1 Myriad Genetics Profile
5.3.2 Myriad Genetics Main Business
5.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.3.4 Myriad Genetics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Biocartis Recent Developments
5.4 Biocartis
5.4.1 Biocartis Profile
5.4.2 Biocartis Main Business
5.4.3 Biocartis Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.4.4 Biocartis Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Biocartis Recent Developments
5.5 IntegraGen
5.5.1 IntegraGen Profile
5.5.2 IntegraGen Main Business
5.5.3 IntegraGen Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.5.4 IntegraGen Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.5.5 IntegraGen Recent Developments
5.6 Perkin Elmer
5.6.1 Perkin Elmer Profile
5.6.2 Perkin Elmer Main Business
5.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.6.4 Perkin Elmer Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Perkin Elmer Recent Developments
5.7 WaferGen Biosystem
5.7.1 WaferGen Biosystem Profile
5.7.2 WaferGen Biosystem Main Business
5.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.7.4 WaferGen Biosystem Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.7.5 WaferGen Biosystem Recent Developments
5.8 Interpace Diagnostics
5.8.1 Interpace Diagnostics Profile
5.8.2 Interpace Diagnostics Main Business
5.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.8.4 Interpace Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Interpace Diagnostics Recent Developments
5.9 Quest Diagnostic
5.9.1 Quest Diagnostic Profile
5.9.2 Quest Diagnostic Main Business
5.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.9.4 Quest Diagnostic Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Quest Diagnostic Recent Developments
5.10 Bio-Rad
5.10.1 Bio-Rad Profile
5.10.2 Bio-Rad Main Business
5.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.10.4 Bio-Rad Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Recent Developments
5.11 AutoGenomics
5.11.1 AutoGenomics Profile
5.11.2 AutoGenomics Main Business
5.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.11.4 AutoGenomics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.11.5 AutoGenomics Recent Developments
5.12 Abbott
5.12.1 Abbott Profile
5.12.2 Abbott Main Business
5.12.3 Abbott Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.12.4 Abbott Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Abbott Recent Developments
5.13 Cepheid
5.13.1 Cepheid Profile
5.13.2 Cepheid Main Business
5.13.3 Cepheid Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.13.4 Cepheid Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Cepheid Recent Developments
5.14 EKF Diagnostics
5.14.1 EKF Diagnostics Profile
5.14.2 EKF Diagnostics Main Business
5.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.14.4 EKF Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.14.5 EKF Diagnostics Recent Developments
5.15 Natera
5.15.1 Natera Profile
5.15.2 Natera Main Business
5.15.3 Natera Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.15.4 Natera Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Natera Recent Developments
5.16 Agilent Technologies
5.16.1 Agilent Technologies Profile
5.16.2 Agilent Technologies Main Business
5.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.16.4 Agilent Technologies Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Agilent Technologies Recent Developments
5.17 Illumina
5.17.1 Illumina Profile
5.17.2 Illumina Main Business
5.17.3 Illumina Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.17.4 Illumina Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Illumina Recent Developments
5.18 Ariosa Diagnostics
5.18.1 Ariosa Diagnostics Profile
5.18.2 Ariosa Diagnostics Main Business
5.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.18.4 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.18.5 Ariosa Diagnostics Recent Developments
5.19 Sequenom
5.19.1 Sequenom Profile
5.19.2 Sequenom Main Business
5.19.3 Sequenom Prenatal and Newborn Genetic Testing Products, Services and Solutions
5.19.4 Sequenom Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2018-2023)
5.19.5 Sequenom Recent Developments
6 North America
6.1 North America Prenatal and Newborn Genetic Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prenatal and Newborn Genetic Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prenatal and Newborn Genetic Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prenatal and Newborn Genetic Testing Market Dynamics
11.1 Prenatal and Newborn Genetic Testing Industry Trends
11.2 Prenatal and Newborn Genetic Testing Market Drivers
11.3 Prenatal and Newborn Genetic Testing Market Challenges
11.4 Prenatal and Newborn Genetic Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
